Expression of PD-L1 is upregulated in response to interferon-gamma (IFN-γ) signaling and responsiveness to PD-1 ICI is associated with preexisting IFN-γ-mediated immune activation that includes tumor-specific major histocompatibility complex (MHC) class II expression [27]. The gene discussed is IFNG; the disease is neoplasm.